GlaxoSmithKline, Gilead Sciences Inc., and Merck & Co. have joined an international partnership to increase the number of HIV drugs available to children in Third World countries. First Lady Laura Bush on Monday announced a collaborative effort on the part of the U.S. government, pharmaceutical companies and the United Nations to maximize the use of pediatric HIV drugs currently available and to speed up the development of new treatments... Abbott Laboratories, Bristol-Myers Squibb, and Pfizer [are also involved]. Generic drug makers involved in the project include Aspen Pharmacare, Aurobindo Pharma, Cipla, Emcure and Ranbaxy.